Email:
support-global@metwarebio.com
Oct 30, 2023
Explore the role of pyruvic acid in cellular metabolism, energy production, and its impact on human health and disease. Learn about the diverse pathways of pyruvic acid metabolism, its functions in energy production, glucose homeostasis, and intermediary metabolism. Discover how dysregulation of pyruvic acid metabolism is linked to conditions such as cancer, metabolic disorders, neurodegenerative diseases, cardiovascular diseases, and liver diseases, highlighting potential therapeutic strategies and implications for human health.
1. Unveiling the Structure and Importance of Pyruvic Acid
2. Pyruvic Acid Metabolism: Powering Cellular Processes
3. The Role of Pyruvic Acid in Human Health and Disease
4. Pyruvic Acid: Implications in Disease Development
.png "Figure_1._The_structure_of_pyruvic_acid_(image_adopted_from_PubChem)")
Pyruvic acid, also known as pyruvate, is a crucial molecule in biochemistry and metabolism and plays a central role in both aerobic and anaerobic metabolism. It serves as a substrate for various metabolic pathways, including the citric acid cycle (Krebs cycle) and the synthesis of amino acids and fatty acids. Additionally, pyruvic acid is involved in cellular respiration, where it is further oxidized to produce ATP, the energy currency of cells. Overall, pyruvic acid is a key molecule that links carbohydrate metabolism to other metabolic processes essential for cellular function and energy production.
The detailed structure of pyruvic acid was elucidated in the mid-20th century through the efforts of several researchers. Pyruvic acid is a simple organic molecule with the chemical formula CH3COCOOH. It consists of a three-carbon chain with a carbonyl group (C=O) at one end and a carboxyl group (COOH) at the other. The molecule exists in equilibrium with its hydrated form, pyruvate, in aqueous solutions.
The discovery of pyruvic acid and its central role in cellular metabolism revolutionized our understanding of biochemistry and paved the way for further research into energy production, metabolism, and disease. Today, pyruvic acid continues to be studied for its diverse physiological functions and potential applications in medicine and biotechnology.
Understanding the diverse pathways of pyruvic acid metabolism provides insights into its role as a central metabolite in cellular energy production and biosynthesis [1,2].
Pyruvic acid is a central metabolite in glycolysis and glycolysis is the primary pathway for pyruvic acid synthesis under aerobic and anaerobic conditions. In this pathway, glucose undergoes a series of enzymatic reactions, ultimately leading to the formation of pyruvate. Key enzymes include hexokinase, phosphofructokinase, and pyruvate kinase. Glycolysis occurs in the cytoplasm and generates ATP and NADH.
Pyruvic acid can be converted back to glucose through gluconeogenesis, which occurs mainly in the liver and kidneys. This pathway involves several enzymes, including pyruvate carboxylase, phosphoenolpyruvate carboxykinase (PEPCK), and fructose-1,6-bisphosphatase. Gluconeogenesis is essential for maintaining blood glucose levels during fasting and starvation.
Pyruvic acid can be converted to acetyl-CoA by the pyruvate dehydrogenase complex (PDC) in the mitochondria. This complex consists of multiple subunits and requires thiamine pyrophosphate (TPP), lipoic acid, coenzyme A (CoA), FAD, and NAD+ as cofactors. The conversion of pyruvate to acetyl-CoA links glycolysis with the TCA cycle, facilitating the oxidation of pyruvate-derived carbon.
![Figure_2_Proximal_pyruvate_metabolism_pathway_[1]](/uploads/image/20240320/Figure_2_Proximal_pyruvate_metabolism_pathway_[1].png "Figure_2_Proximal_pyruvate_metabolism_pathway_[1]")
Acetyl-CoA generated from pyruvate enters the TCA cycle, where it undergoes a series of enzymatic reactions to produce NADH, FADH2, and GTP. Key enzymes in the TCA cycle include citrate synthase, aconitase, isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, succinyl-CoA synthetase, succinate dehydrogenase, fumarase, and malate dehydrogenase. The TCA cycle serves as a central hub for energy production and the generation of precursor metabolites for biosynthesis.
Pyruvic acid can undergo transamination to form alanine in a reversible reaction catalyzed by alanine transaminase (ALT). This process involves the transfer of an amino group from an amino acid (usually glutamate) to pyruvate, yielding alanine and α-ketoglutarate. Alanine can serve as a substrate for gluconeogenesis in the liver.
Under anaerobic conditions, pyruvic acid can be reduced to lactic acid by lactate dehydrogenase (LDH). This reaction regenerates NAD+ from NADH, allowing glycolysis to continue in the absence of oxygen. Lactic acid fermentation is common in muscles during strenuous exercise when oxygen availability is limited.
Pyruvate serves as a critical intermediate in cellular respiration, linking glycolysis to the TCA cycle and oxidative phosphorylation. DUing glycolysis, glucose is metabolized to pyruvate, generating ATP and NADH in the cytoplasm. In aerobic conditions, pyruvate enters the mitochondria, where it undergoes oxidative decarboxylation by the pyruvate dehydrogenase complex (PDH) to form acetyl-CoA, a substrate for the TCA cycle. Acetyl-CoA generated from pyruvate oxidation fuels the TCA cycle, leading to the production of reducing equivalents (NADH and FADH2) and ATP through oxidative phosphorylation in the electron transport chain (ETC).
Pyruvate plays a crucial role in gluconeogenesis, the process by which glucose is synthesized from non-carbohydrate precursors. In the liver and kidneys, pyruvate can be converted to oxaloacetate and then to glucose through a series of enzymatic reactions. Gluconeogenesis ensures the maintenance of blood glucose levels during fasting and periods of increased energy demand.
Pyruvate serves as a central hub in intermediary metabolism, participating in the synthesis of various biomolecules. It can be converted to oxaloacetate or acetyl-CoA, which are precursors for the synthesis of amino acids, fatty acids, and cholesterol. Through its conversion to oxaloacetate, pyruvate contributes to the replenishment of TCA cycle intermediates, facilitating the continuous operation of cellular metabolism.
Pyruvate metabolism plays a critical role in maintaining cellular redox balance through the generation and utilization of NADH and NAD+. The interconversion of pyruvate and lactate helps regulate the cytosolic NADH/NAD+ ratio, influencing cellular redox status and metabolic signaling pathways.
Emerging evidence suggests that pyruvate may function as a signaling molecule, influencing various cellular processes and metabolic pathways. Pyruvate-derived metabolites, such as acetyl-CoA and oxaloacetate, serve as substrates for post-translational modifications, epigenetic regulation, and signal transduction pathways.
Pyruvate metabolism is dysregulated in cancer cells, leading to increased glycolysis even in the presence of oxygen, known as the Warburg effect [3]. Cancer cells preferentially utilize glycolysis-derived pyruvate to support rapid proliferation and tumor growth. High levels of pyruvate fuel biosynthetic pathways, including the synthesis of amino acids, nucleotides, and lipids, supporting the demands of cancer cell proliferation. Targeting pyruvate metabolism in cancer cells has emerged as a potential therapeutic strategy [4-6]. For example, inhibition of lactate dehydrogenase (LDH), the enzyme that converts pyruvate to lactate, can suppress tumor growth and enhance sensitivity to chemotherapy.
Dysregulation of pyruvate metabolism is associated with metabolic disorders such as diabetes and obesity. In diabetes, impaired glucose metabolism leads to elevated levels of pyruvate, which can contribute to hyperglycemia and insulin resistance [7,8]. Excess pyruvate can be converted to lactate or stored as fat, contributing to the development of obesity and associated metabolic complications [9]. Targeting pyruvate metabolism pathways, such as pyruvate dehydrogenase kinase (PDK) inhibitors, has shown promise in preclinical studies for the treatment of metabolic disorders [10].
Altered pyruvate metabolism has been implicated in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease [11-14]. Dysfunctional pyruvate metabolism contributes to mitochondrial dysfunction, oxidative stress, and neuronal damage in these conditions. Decreased activity of pyruvate dehydrogenase complex (PDH) and impaired mitochondrial function lead to reduced ATP production and neuronal energy deficits. Modulating pyruvate metabolism and enhancing mitochondrial function have emerged as potential therapeutic approaches for neurodegenerative diseases.
Dysregulated pyruvate metabolism is observed in cardiovascular diseases such as heart failure and ischemic heart disease [15,16]. Altered pyruvate metabolism contributes to impaired cardiac energy metabolism, mitochondrial dysfunction, and oxidative stress. Therapeutic strategies targeting pyruvate metabolism, including PDK inhibitors and pyruvate supplementation, have shown beneficial effects in preclinical models of heart disease.
Dysregulated pyruvate metabolism is implicated in liver diseases such as non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC). Altered pyruvate metabolism contributes to hepatic steatosis, inflammation, and fibrosis in NAFLD. Targeting pyruvate metabolism pathways, such as PDK inhibition or activation of pyruvate oxidation, holds promise for the treatment of liver diseases [17, 18].
1.Gray, L. R., Tompkins, S. C., & Taylor, E. B. (2014). Regulation of pyruvate metabolism and human disease. Cellular and molecular life sciences : CMLS, 71(14), 2577–2604. https://doi.org/10.1007/s00018-013-1539-2
2.Yiew, N. K. H., & Finck, B. N. (2022). The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism. American journal of physiology. Endocrinology and metabolism, 323(1), E33–E52. https://doi.org/10.1152/ajpendo.00074.2022
3.Upadhyay, M., Samal, J., Kandpal, M., Singh, O. V., & Vivekanandan, P. (2013). The Warburg effect: insights from the past decade. Pharmacology & therapeutics, 137(3), 318–330. https://doi.org/10.1016/j.pharmthera.2012.11.003
4.Rong, Y., Wu, W., Ni, X., Kuang, T., Jin, D., Wang, D., & Lou, W. (2013). Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 34(3), 1523–1530. https://doi.org/10.1007/s13277-013-0679-1
5.Zhao, Y., Butler, E. B., & Tan, M. (2013). Targeting cellular metabolism to improve cancer therapeutics. Cell death & disease, 4(3), e532. https://doi.org/10.1038/cddis.2013.60
6.Ward, R. A., Brassington, C., Breeze, A. L., Caputo, A., Critchlow, S., Davies, G., et.al. (2012). Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation. Journal of medicinal chemistry, 55(7), 3285–3306. https://doi.org/10.1021/jm201734r
7.Park, B. Y., Jeon, J. H., Go, Y., Ham, H. J., Kim, J. E., Yoo, E. K., Kwon, W. H., Jeoung, et.al. (2018). PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels. Diabetes, 67(10), 2054–2068. https://doi.org/10.2337/db17-1529
8.Chang, I., Cho, N., Koh, J. Y., & Lee, M. S. (2003). Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes. Diabetologia, 46(9), 1220–1227. https://doi.org/10.1007/s00125-003-1171-z
9.Thoudam, T., Ha, C. M., Leem, J., Chanda, D., Park, J. S., Kim, H. J., Jeon, J. H., et.al. (2019). PDK4 Augments ER-Mitochondria Contact to Dampen Skeletal Muscle Insulin Signaling During Obesity. Diabetes, 68(3), 571–586. https://doi.org/10.2337/db18-0363
10.Kalman, D., Colker, C. M., Wilets, I., Roufs, J. B., & Antonio, J. (1999). The effects of pyruvate supplementation on body composition in overweight individuals. Nutrition (Burbank, Los Angeles County, Calif.), 15(5), 337–340. https://doi.org/10.1016/s0899-9007(99)00034-9
11.Martin, E., Rosenthal, R. E., & Fiskum, G. (2005). Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. Journal of neuroscience research, 79(1-2), 240–247. https://doi.org/10.1002/jnr.20293
12.Parnetti, L., Gaiti, A., Polidori, M. C., Brunetti, M., Palumbo, B., Chionne, F., Cadini, D., Cecchetti, R., & Senin, U. (1995). Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease. Neuroscience letters, 199(3), 231–233. https://doi.org/10.1016/0304-3940(95)12058-c
13.Sheu, K. F., Kim, Y. T., Blass, J. P., & Weksler, M. E. (1985). An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Annals of neurology, 17(5), 444–449. https://doi.org/10.1002/ana.410170505
14.Ahmed, S. S., Santosh, W., Kumar, S., & Christlet, H. T. (2009). Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection. Journal of biomedical science, 16(1), 63. https://doi.org/10.1186/1423-0127-16-63
15.Piao, L., Fang, Y. H., Cadete, V. J., Wietholt, C., Urboniene, D., Toth, P. T., et.al. (2010). The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. Journal of molecular medicine (Berlin, Germany), 88(1), 47–60. https://doi.org/10.1007/s00109-009-0524-6
16.Fillmore, N., & Lopaschuk, G. D. (2013). Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. Biochimica et biophysica acta, 1833(4), 857–865. https://doi.org/10.1016/j.bbamcr.2012.08.014
17.Go, Y., Jeong, J. Y., Jeoung, N. H., Jeon, J. H., Park, B. Y., Kang, H. J., Ha, C. M.,et.al. (2016). Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis. Diabetes, 65(10), 2876–2887. https://doi.org/10.2337/db16-0223
18.Kim, M. J., Lee, H., Chanda, D., Thoudam, T., Kang, H. J., Harris, R. A., & Lee, I. K. (2023). The Role of Pyruvate Metabolism in Mitochondrial Quality Control and Inflammation. Molecules and cells, 46(5), 259–267. https://doi.org/10.14348/molcells.2023.2128
Read More:
Lactic acid: Key Roles in Human Metabolism, Diseases, and Health Implications
Unveiling Ornithine: Beyond the Urea Cycle, A Multifaceted Player in Health
